EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment for joint inflammation



Treatment for joint inflammation



Official Gazette of the United States Patent & Trademark Office Patents 1261(2), Aug 13



The invention provides the use of a glucocorticoid substance which has a minimal systemic effect in the manufacture of a medicament for oral or rectal administration for non-topical use in the treatment of joint inflammation.

(PDF 0-2 workdays service: $29.90)

Accession: 035980221

Download citation: RISBibTeXText



Related references

Treatment of purulent hoof joint inflammation in cattle by joint resection--results. Tierarztliche Praxis 16(2): 123-131, 1988

Purulent inflammation of the carpal joint of calves and its treatment by joint resection. Tierarztliche Praxis 24(3): 233-242, 1996

Purulent inflammation of the fetlock joint in cattle--treatment by joint resection. Tierarztliche Praxis 25(2): 123-129, 1997

Carpal joint inflammation in calves--treatment by joint resection. Tierarztliche Praxis 24(3): 233-242, 1996

MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis. Scandinavian Journal of Rheumatology 45(2): 99-102, 2016

Positive synovial vascularity in patients with low disease activity indicates smouldering inflammation leading to joint damage in rheumatoid arthritis: time-integrated joint inflammation estimated by synovial vascularity in each finger joint. Rheumatology 52(3): 523-528, 2013

Joint Meeting of the 14 European Workshop on Inflammation and the British Inflammation Research Association on Neurogenic Inflammation, Cell Adhesion Molecules and Future Trends in Inflammation Therapy, London, England, UK, July 1-3, 1992. Agents & Actions 38(SPEC CONF ISSUE): C3-C149, 1993

Neurogenic Inflammation, Cell Adhesion Molecules and Future Trends in Inflammation Therapy. Proceedings of 14th European Workshop on Inflammation, Joint Meeting with the British Inflammation Research Association. London, 1-3 July 1992. Agents and Actions 38 Spec No: C3-149, 1993

Does facet joint inflammation induce radiculopathy?: an investigation using a rat model of lumbar facet joint inflammation. Spine 32(4): 406-412, 2007

Macrophages in inflammation and cancer joint meeting of the british inflammation research association biras and the uk northern inflammation group alderley park cheshire england uk december 12 1988. Agents & Actions 31(1-2): 39-42, 1990

Diagnosis and treatment of inflammation of the temporomandibular joint. Seminars in Arthritis and Rheumatism 12(1): 44-51, 1982

Immunoglobulins in the treatment of juvenile chronic joint inflammation. Reumatologia (Warsaw) 34(4): 871, 1996

Emergency treatment of acute inflammation of the temporomandibular joint. Journal of Prosthetic Dentistry 50(6): 827-829, 1983

Treatment of rheumatoid joint inflammation with intrasynovial triamcinolone. Journal of Rheumatology 23(9): 1666-1667, 1996

Conservative Treatment of Ichorous Inflammation of the Knee-Joint. Annals of Surgery 9: 231-233, 1889